Table3.
Wark, 200926 | Hoffmeister, 201027 | ||||
---|---|---|---|---|---|
Population | HPFS: 1986–2004 | 33 GE clinics in Germany | |||
% Female | 0% | 38% | |||
Prevalence | Odds Ratios | Prevalence | Prevalence Ratios | ||
N Screened | 0 FDR with CRC | 23 880 | 2 929 | ||
1 FDR | 3 445 | - | |||
1+ FDR | 3 770 | 391 | |||
2+ FDR | 325 | - | |||
N (%) with any adenomaa |
0 FDR | 2 378 (10.0) | Refb,c | 892 (30.5) | Refb, c |
1 FDR | 532 (15.4) | 1.75 (1.60–1.92) | - | - | |
1+ FDR | 594 (15.8) | 1.75 (1.60–1.91) | 157 (40.2) | 1.17 (0.95–1.44) | |
2+ FDR | 62 (19.1) | 2.36 (1.84–3.04) | - | - | |
Women | 0 FDR | - | 340 (23.1) | Refb, c | |
1 FDR | - | 58 (30.7) | 1.42 (1.02–1.97) | ||
Men | 0 FDR | - | 552 (37.8) | Refb, c | |
1 FDR | - | 99 (49.0) | 1.42 (1.02–1.97) | ||
N (%) with adv. adenomad |
0 FDR | 1 184 (5.0) | Refb, e | 319 (10.9) | Refb, e |
1 FDR | 264 (7.7) | 0.97 (0.80–1.17) | - | - | |
1+ FDR | 297 (7.9) | - | 63 (16.1) | 1.33 (1.00–1.76) | |
2+ FDR | 33 (10.2) | 1.08 (0.65–1.79) | - | - | |
Women | 0 FDR | - | 122 (8.3) | Refb, e | |
1 FDR | - | 21 (11.1) | 0.96 (0.55–1.67) | ||
Men | 0 FDR | - | 197 (13.5) | 1.46 (1.06–2.02) | |
1 FDR | - | 42 (20.8) | 2.22 (1.47–3.33) | ||
N (%) with 2+ distal adenomas |
0 FDR | 470 (1.9) | Refb,f | - | |
1 FDR | 124 (3.4) | 1.26 (1.02–1.63) | - | ||
1+ FDR | 142 (3.6) | - | - | ||
2+ FDR | 18 (5.2) | 1.76 (0.98–3.15) | - | ||
N (%) with 2+ proximal adenomas |
0 FDR | 363 (1.5) | - | ||
1 FDR | - | - | |||
1+ FDR | 137 (3.5) | - | |||
2+ FDR | - | - |
Wark: Non-advanced and advanced adenomas; Hoffmeister: Non-advanced and advanced adenomas and CRC
Wark: adjusted age, previous endoscopy, indication, aspirin, multivitamin, smoking, red meat, alcohol, folate, calcium, BMI, physical activity, total energy intake ; Hoffmeister: age at colonoscopy, gender, education, HRT use, BMI, physical activity, alcohol, red meat consumption
Wark: Odds ratio: adenoma vs. no adenoma within each family history level, Hoffmeister: Prevalence ratio between family history levels
Wark: Size ≥10mm *or* tubulo/villous structure *or* carcinoma in situ; Hoffmeister: Size ≥10mm *or* tubulo/villous structure *or* severe dysplasia *or* CRC
Wark: Odds ratio: advanced adenoma vs. non-advanced adenoma within each family history level, Hoffmeister: Prevalence ratio between family history levels
Wark: Rates of multiple vs. single adenoma